These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses. Hinshaw JL; Shadid AM; Nakada SY; Hedican SP; Winter TC; Lee FT AJR Am J Roentgenol; 2008 Oct; 191(4):1159-68. PubMed ID: 18806159 [TBL] [Abstract][Full Text] [Related]
64. Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. Buy X; Lang H; Garnon J; Sauleau E; Roy C; Gangi A AJR Am J Roentgenol; 2013 Dec; 201(6):1353-61. PubMed ID: 24261377 [TBL] [Abstract][Full Text] [Related]
65. Cryoablation of small kidney tumors. Zondervan PJ; Buijs M; de la Rosette JJ; van Delden O; van Lienden K; Laguna MP Int J Surg; 2016 Dec; 36(Pt C):533-540. PubMed ID: 27500963 [TBL] [Abstract][Full Text] [Related]
66. CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation. Wetley KA; Abel EJ; Dreyfuss LD; Huang W; Brace CL; Wells SA Abdom Radiol (NY); 2020 Sep; 45(9):2810-2824. PubMed ID: 32715335 [TBL] [Abstract][Full Text] [Related]
67. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up. Forauer AR; Dewey BJ; Seigne JD Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958 [TBL] [Abstract][Full Text] [Related]
73. Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center. Wilcox Vanden Berg RN; Calderon LP; LaRussa S; Enobakhare O; Craig K; Del Pizzo J; McClure TD Clin Imaging; 2021 Aug; 76():199-204. PubMed ID: 33964597 [TBL] [Abstract][Full Text] [Related]
74. Outcome of nephron-sparing surgery for T1b renal cell carcinoma. Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528 [TBL] [Abstract][Full Text] [Related]
75. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience. Tanagho YS; Bhayani SB; Kim EH; Figenshau RS J Endourol; 2013 Dec; 27(12):1477-86. PubMed ID: 24283518 [TBL] [Abstract][Full Text] [Related]
76. Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients. Breen DJ; Bryant TJ; Abbas A; Shepherd B; McGill N; Anderson JA; Lockyer RC; Hayes MC; George SL BJU Int; 2013 Oct; 112(6):758-65. PubMed ID: 23581293 [TBL] [Abstract][Full Text] [Related]
77. Long-term outcomes after percutaneous renal cryoablation performed with adjunctive techniques. Khan F; Ho AM; Jamal JE; Gershbaum MD; Katz AE; Hoffmann JC Clin Imaging; 2018; 50():62-67. PubMed ID: 29324328 [TBL] [Abstract][Full Text] [Related]
78. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study. Hasegawa T; Yamanaka T; Gobara H; Miyazaki M; Takaki H; Sato Y; Inaba Y; Yamakado K Jpn J Radiol; 2018 Sep; 36(9):551-558. PubMed ID: 29968201 [TBL] [Abstract][Full Text] [Related]
79. Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation. Bang HJ; Littrup PJ; Goodrich DJ; Currier BP; Aoun HD; Heilbrun LK; Vaishampayan U; Adam B; Goodman AC J Vasc Interv Radiol; 2012 Jun; 23(6):770-7. PubMed ID: 22538119 [TBL] [Abstract][Full Text] [Related]
80. Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma. Yang F; Zhou Q; Xing N J Cancer Res Clin Oncol; 2020 Jan; 146(1):261-272. PubMed ID: 31677114 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]